Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potential Structural Biomarkers in 3D Images Validated by the First Functional Biomarker for Early Age-Related Macular Degeneration - ALSTAR2 Baseline.
Fasih-Ahmad S, Wang Z, Mishra Z, Vatanatham C, Clark ME, Swain TA, Curcio CA, Owsley C, Sadda SR, Hu ZJ. Fasih-Ahmad S, et al. Among authors: sadda sr. medRxiv [Preprint]. 2023 Sep 11:2023.09.10.23295309. doi: 10.1101/2023.09.10.23295309. medRxiv. 2023. Update in: Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):1. doi: 10.1167/iovs.65.2.1 PMID: 37745353 Free PMC article. Updated. Preprint.
Risk assessment models: considerations prior to use in clinical practice.
Darzi AJ, Busse JW, Torabiardakani K, Phillips M, Thabane L, Bhandari M, Borrelli E, Steel DH, Wykoff CC, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. Darzi AJ, et al. Eye (Lond). 2024 Dec 18. doi: 10.1038/s41433-024-03557-5. Online ahead of print. Eye (Lond). 2024. PMID: 39695254 No abstract available.
Retinal fluid quantification using a novel deep learning algorithm in patients treated with faricimab in the TRUCKEE study.
Aziz AA, Khanani AM, Khan H, Lauer E, Khanani I, Mojumder O, Khanani ZA, Khan H, Gahn GM, Graff JT, Abbey AM, Almeida DRP, Barakat MR, Corradetti G, Graff JM, Haug SJ, Nielsen JS, Sheth VS, Sadda SR, Hadas I, Benyamini G, Nahen K, Mohan N. Aziz AA, et al. Among authors: sadda sr. Eye (Lond). 2024 Dec 11. doi: 10.1038/s41433-024-03532-0. Online ahead of print. Eye (Lond). 2024. PMID: 39663398
Visual Loss in Geographic Atrophy: Learnings From the Lampalizumab Trials.
Anegondi N, Steffen V, Sadda SR, Schmitz-Valckenberg S, Tufail A, Csaky K, Lad EM, Kaiser PK, Ferrara D, Chakravarthy U. Anegondi N, et al. Among authors: sadda sr. Ophthalmology. 2024 Nov 22:S0161-6420(24)00742-5. doi: 10.1016/j.ophtha.2024.11.017. Online ahead of print. Ophthalmology. 2024. PMID: 39581330 Free article.
Pilot and feasibility studies in ophthalmology: fundamental keys to success.
Nanji K, Phillips M, Thabane L, Tham YC, Wong TY, Steel DH, Munk MR, Wykoff CC, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. Nanji K, et al. Eye (Lond). 2024 Nov 21. doi: 10.1038/s41433-024-03413-6. Online ahead of print. Eye (Lond). 2024. PMID: 39572846 No abstract available.
Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial.
Corradetti G, Karamat A, Srinivas S, Lindenberg S, Velaga SB, Corvi F, Attiku Y, Nittala MG, Desai D, Zhu L, Abulon D, Sadda SR. Corradetti G, et al. Among authors: sadda sr. Graefes Arch Clin Exp Ophthalmol. 2024 Nov 14. doi: 10.1007/s00417-024-06676-7. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39538001
634 results